Sangamo Biosciences (NASDAQ: SGMO) reported Q1 EPS of ($0.23), $0.03 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $3.43 million versus the consensus estimate of $4.25 million.

For earnings history and earnings-related data on Sangamo Biosciences (SGMO) click here.